氯法齐明增强结核性脑膜炎小鼠模型标准方案活性
该研究在结核性脑膜炎小鼠模型中评估氯法齐明作为标准一线抗结核方案辅助药物的效果。小鼠脑内感染结核分枝杆菌后治疗6周,加用氯法齐明显著降低脑组织细菌负荷并减轻脑组织炎症。氯法齐明在脑脊液穿透有限的情况下仍达到可测脑组织浓度,支持进一步临床评估。
要点
- 氯法齐明辅助标准一线方案可显著降低结核性脑膜炎小鼠脑组织细菌负荷。
- 氯法齐明脑脊液穿透有限,但仍达到可测脑组织浓度并减轻脑组织炎症。
- 结果支持对氯法齐明辅助治疗结核性脑膜炎开展进一步临床研究。
核心结论
- 氯法齐明增强标准一线抗结核方案的杀菌活性并减轻脑组织炎症,支持进一步研究和临床评估其用于结核性脑膜炎。
研究设计与样本
- 小鼠脑内感染结核分枝杆菌后治疗6周,评估氯法齐明作为标准一线抗结核方案辅助药物的效果。
主要发现
- 加用氯法齐明显著降低脑组织细菌负荷。
- 氯法齐明在脑脊液穿透有限的情况下仍达到可测脑组织浓度。
- 加用氯法齐明减轻脑组织炎症。
临床怎么用
- 提示氯法齐明可作为结核性脑膜炎辅助治疗的候选药物,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tuberculous meningitis causes substantial mortality due to limited penetration of antibiotics to the central nervous system and excessive neuroinflammation. This study evaluated clofazimine as an adjunct to the standard first-line tuberculosis regimen, in a mouse model. Mice were infected intracerebrally with Mycobacterium tuberculosis and treated for 6 weeks. Addition of clofazimine markedly reduced the brain bacterial burden, achieving measurable brain tissue concentrations despite minimal cerebrospinal fluid penetration, as well as attenuated brain tissue inflammation. These findings indicate that clofazimine enhances bactericidal activity of the standard regimen and mitigate neuroinflammation, supporting further investigation and clinical evaluation for tuberculous meningitis.
引用
- Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, et al. Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis. J Infect Dis. 2026. PMID: 41729737. doi:10.1093/infdis/jiag123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。